Article

Splenic pathology in immune thrombocytopenia.

Journal of Clinical Pathology (Impact Factor: 2.44). 10/1985; 38(9):985-8. DOI: 10.1136/jcp.38.9.985
Source: PubMed

ABSTRACT Splenic pathology was analysed in 73 patients with immune thrombocytopenic purpura who underwent splenectomy for bleeding that had been resistant to adrenocorticosteroids. The mean splenic weight was 100 g. The only notable macroscopic feature was the prominence of Malpighian corpuscles in 15 cases. Microscopic examination showed formation of germinal centres in the lymphoid tissue of the white pulp in 40 cases, prominence of the histiocytes in the red pulp in 18 cases, and infiltration with neutrophils in the same area in 49 cases. Myeloid metaplasia throughout the splenic tissue was minimal in 58 cases, moderate in 15, and extreme in two. No distinguishing features were found in the spleen from patients who had not received previous immunosuppressive treatment (n = 3), those treated with prednisone (1 mg/kg/day) for a median of 14 days (n = 62), or those who had received the same dose of prednisone and additional azathioprine or cyclophosphamide (2 mg/kg/day) for a median of four weeks (n = 8). No correlation could be shown between histological features and the age of the patient or titre of antiplatelet antibodies. Similarly, no distinguishing features were found in patients with associated systemic lupus erythematosus (n = 8), hyperthyroidism (n = 6), immune haemolysis (n = 3), or recent viral illness (n = 3).

1 Bookmark
 · 
127 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Symptomatic immune thrombocytopenia is a life-threatening situation which is conventionally treated in the adult with prednisone, although subsequent splenectomy is frequently unavoidable. Recently, high-dose intravenous gammaglobulin has been reported to be an effective alternative option, particularly in children. To determine the role of this agent in adults a controlled prospective trial has been undertaken. Previously untreated patients with immune thrombocytopenia were randomised to compare oral prednisone (1 mg/kg/day: Group 1: n=13) to high-dose intravenous gammaglobulin (400 mg/kg on days 1 through 5: Group 2: n=7), or a combination of both agents given on the same schedule (Group 3: n=12). The time from diagnosis to commencement of treatment, initial platelet counts, age and sex were comparable in the three groups. At this interim analysis there has been no mortality, but one patient has suffered a cerebrovascular accident. Objective response, defined as a platelet count greater than 50109/l, was achieved in a median of 5, 5 and 3 days, whereas the time taken to reach peak counts were 9, 5 and 7 days, respectively. The relapse rates, percentage of patients subsequently requiring splenectomy for control of symptomatic bleeding and the postoperative course was comparable between the three groups. These data, although preliminary, re-emphasize differences between the paediatric and adult forms of immune thrombocytopenia and also suggest in the latter patients a need for caution before advocating replacement of prednisone by gammaglobulin as the primary form of treatment.
    Annals of Hematology 06/1989; 59(1):92-95. · 2.87 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In order to understand more specific abnormalities of humoral autoimmunity, we studied 31 spleens from immune thrombocytopenia (ITP) patients and 36 control spleens. Detailed analysis identified at least two different splenic structures accommodating proliferating B-cells, classical germinal centers (GC) and proliferative lymphoid nodules (PLN). PLN were characterized by proliferating Ki67(+) B-cells close to follicular dendritic cells (FDC) and lacked polarization into dark and light zones. As opposed to cells in GC, proliferating B-cells in PLN lacked expression of Bcl6. In both PLN and GC of ITP spleens, the density of T-cells was significantly reduced. Both T follicular helper cells (T(FH)) and regulatory T-cells were reduced within PLN of ITP spleens suggesting a defect of tolerance related to a loss of T-cell control. Within PLN of ITP, but not controls, abundant platelet glycoprotein (GP) IIb/IIIa autoantigens was found in IgM containing immune complexes tightly bound to FDC and closely approximated to proliferating B cells. GP IV was found less often, but not in the same PLN as GPIIb/IIIa. Autoantigens were not found in the GC of ITP or controls indicating that PLN are the sites of autoantigen stimulation in ITP potentially related to a lack of control by T-cells and/or the present autoantigen.
    Blood 09/2012; · 9.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The spleen plays a central role in the pathogenesis of chronic idiopathic thrombocytopenic purpura (ITP); it produces massive quantities of antiplatelet antibodies, leading to accelerated phagocytosis of platelets. Lymphoid hyperplasia typically occurs in the spleen, characterized by large numbers of lymphatic nodules with active germinal centers. Whether changes in splenic microcirculatory pathways also occur is not known. We have studied this question by scanning electron microscopy of corrosion casts, comparing spleens removed from patients with ITP with normal spleens obtained from organ transplant donors. The casts demonstrate two major changes in microcirculatory pathways in ITP. Firstly, a striking proliferation of arterioles and capillaries is found in the white pulp and marginal zone (MZ), seen as extensive vascularization in 92.3% of lymphatic nodules (n = 191) versus 0.6% (n = 224) in normal spleens. Secondly, the marginal sinus, a series of flattened, anastomosing vascular spaces between the white pulp and MZ, is absent in 89.4% of lymphatic nodules versus 4.9% in normal spleens. The cause of these microcirculatory changes, which may not be exclusive to ITP, is presently unknown. Absence of the marginal sinus may affect distribution of blood flow through the MZ such that platelets spend increased amounts of time in the proximity of macrophages. In the presence of antiplatelet antibodies found in ITP spleens, this delayed transit would lead to greatly increased platelet destruction.
    Blood 10/1991; 78(6):1485-9. · 9.78 Impact Factor

Full-text (2 Sources)

Download
48 Downloads
Available from
May 27, 2014